Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Clascoterone by Cosmo Pharmaceuticals for Pancreatic Cancer: Likelihood of Approval
Clascoterone is under clinical development by Cosmo Pharmaceuticals and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...
Clascoterone by Cosmo Pharmaceuticals for Prostate Cancer: Likelihood of Approval
Clascoterone is under clinical development by Cosmo Pharmaceuticals and currently in Phase I for Prostate Cancer. According to GlobalData, Phase...
Rifamycin sodium CR by Cosmo Pharmaceuticals for Bacterial Infections: Likelihood of Approval
Rifamycin sodium CR is under clinical development by Cosmo Pharmaceuticals and currently in Phase II for Bacterial Infections. According to...
Rifamycin sodium CR by Cosmo Pharmaceuticals for Hepatic Encephalopathy: Likelihood of Approval
Rifamycin sodium CR is under clinical development by Cosmo Pharmaceuticals and currently in Phase II for Hepatic Encephalopathy. According to...
Androgenetic Alopecia by Cosmo Pharmaceuticals for Androgenic Alopecia: Likelihood of Approval
Androgenetic Alopecia is under clinical development by Cosmo Pharmaceuticals and currently in Phase III for Androgenic Alopecia. According to GlobalData,...
Rifamycin sodium CR by Cosmo Pharmaceuticals for Hepatic Encephalopathy: Likelihood of Approval
Rifamycin sodium CR is under clinical development by Cosmo Pharmaceuticals and currently in Phase II for Hepatic Encephalopathy. According to...
CB-0135 by Cosmo Pharmaceuticals for Proctitis: Likelihood of Approval
CB-0135 is under clinical development by Cosmo Pharmaceuticals and currently in Phase II for Proctitis. According to GlobalData, Phase II...
CB-0135 by Cosmo Pharmaceuticals for Limited/Distal Colitis: Likelihood of Approval
CB-0135 is under clinical development by Cosmo Pharmaceuticals and currently in Phase II for Limited/Distal Colitis. According to GlobalData, Phase...